about
Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic reviewEnhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.The benefit of everolimus in recurrent/epithelioid angiosarcoma patients: Case reports and literature review.Poly(ethylene glycol)-co-methacrylamide-co-acrylic acid based nanogels for delivery of doxorubicin.Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New therapies in soft tissue sarcoma.
@en
New therapies in soft tissue sarcoma.
@nl
type
label
New therapies in soft tissue sarcoma.
@en
New therapies in soft tissue sarcoma.
@nl
prefLabel
New therapies in soft tissue sarcoma.
@en
New therapies in soft tissue sarcoma.
@nl
P2093
P2860
P50
P1476
New therapies in soft tissue sarcoma
@en
P2093
Anna Maria Frezza
Bruno Vincenzi
Giuseppe Tonini
P2860
P304
P356
10.1517/14728211003592108
P407
P577
2010-06-01T00:00:00Z